OraVital is a rapidly-growing innovator and a newsmaker when it comes to achieving optimal oral health, and reducing oral-systemic health risks. Here are just a few examples of OraVital news releases and articles that have been covered by the dental trade media.
In November 2016, Bradley Bale, Amy Doneen, and David Vigerust published a paper that established a relationship between specific oral pathogens and arterial disease. Their review demonstrates the need to properly assess risk factors and evaluate our current methods of diagnosis and treatment. It is no longer acceptable to assess periodontal disease based on clinical signs alone…
Dental professionals are frontline oral health advocates. Oral Systemic education must be included in our standard care. We repeat treatments and/or therapies yet, our clients continue to have active infections. Yes, change is challenging, however it’s time we talked about addressing the root causes…
Patients with gum disease have worse outcomes with COVID-19 (SARS-CoV-2) and CVD, yet 80% of patients have gum disease despite regular care. This is a crisis. Bleeding gums matter!
OraVital, The Oral Infection Experts, will kick off its 2017 KOL Access Webinar Series with two pioneers of the oral-systemic health movement — Dr. Bradley Bale and Dr. Amy Doneen
The 2017 KOL Access Webinar Series from OraVital Inc. will kick off with a pair of free sessions from pioneers in the oral-systemic health movement, Bradley Bale, MD, and Amy Doneen
OraVital recently signed a distribution agreement with Stat Health Group, making the company its exclusive sales agent in the United Kingdom.
During the 2017 Chicago Midwinter Meeting, OraVital (Toronto, Ontario) will unveil what the company is calling a “dental industry first”—a guarantee on the effectiveness of its OraVital System against gingivitis and periodontal disease.
Oravital Inc., the manufacturer of the Oravital System for the diagnosis and treatment of periodontal disease and halitosis, will be making its debut at the Chicago Midwinter Dental Meeting at the McCormick Convention Center
Oravital Inc., which recently launched the Oravital periodontal and breath odor diagnosis and treatment system into the U.S. professional dental market, will be making its debut at the Greater New York Dental Meeting at the Jacob K. Javits Convention Center
Another common misperception is that these anti-bacterial rinses can’t possibly penetrate the gingival sulcus. However, in the case of the OraVital System, the rinses are actually a slurry of antibiotic suspended in liquid versus just a liquid antibiotic.
Cleaning between the teeth at the gum line is absolutely needed! On the other hand, there is not one published article that can be cited showing floss is superior to other interproximal aids, in spite of our beliefs. Why should flossing get a free pass when in other situations we always say, ‘Show me the proof?
The company is OraVital Inc. The services consist of a proprietary protocol of advanced microbiology tests-BiofilmDNA and BiofilmGS (Gram stain)-combined with a personalized regimen of prescribed antibiotic/antifungal and antimicrobial rinses or cream for the oral cavity.
Oravital® Clinics have an extremely high success rate treating even very serious bad breath problems using this procedure.
The concept that there is a connection between periodontal disease and systemic health is not new. Dr. Willoughby Miller, in 1891, recognized and outlined the concept in a book called The Dental Cosmos, describing the mouth as a focus of infection where microorganisms or their waste products obtain entrance to parts of the body adjacent to or remote from the mouth.
Over the last 10 years that I have been treating halitosis, most of my patients were adults, but surprisingly, two of my most recent patients were children. Periodontal disease is known to be a cause of breath odor in adults, but a common assumption is that children are too young to have periodontal disease, so, therefore, they shouldn’t have chronic breath odor.
By determining the etiology of the lesion and initiating appropriate treatment, oral health professionals can reverse the disease process and prevent bone loss.
At least 10 years ago, it was exciting and daunting to begin the oral-systemic discussion with dentists, hygienists, and assistants who were eager to raise the gold standard of care for their patients.
PANDAS is an acronym for Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections. This is a condition that affects a small group of children resulting in a sudden and abrupt onset of Obsessive Compulsive Disorder (OCD) symptoms.
Oral infections causing periodontal disease and halitosis are notoriously difficult to diagnose and treat, with 75% of the population continuing to have signs of periodontal disease despite their clinicians’ best efforts. Effective diagnosis and treatment is essential not only for quality of life, but also because of the link between oral infections and serious systemic conditions.
Treatment of patients with breath concerns is a difficult process, because no formal training currently exists in dental or dental hygiene schools. The perception of halitosis is that it is related to poor oral hygiene or due to a medical concern. However, oral bacteria—mainly periodontal pathogens—are the most common cause of halitosis.
There is substantial evidence indicating that most forms of periodontal disease are specific infections caused by an overgrowth of mainly anaerobic bacteria species.